| Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review |
47 |
| Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review |
22 |
| Role of SREBPs in Liver Diseases: A Mini-review |
21 |
| Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials |
19 |
| Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment |
18 |
| HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study |
15 |
| Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury |
13 |
| Fatty Liver Disease and Gut Microbiota: A Comprehensive Update |
12 |
| Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency |
11 |
| Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B |
10 |
| A Review on the Management of Biliary Complications after Orthotopic Liver Transplantation |
10 |
| Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies |
9 |
| Differentiating Cystic Liver Lesions: A Review of Imaging Modalities, Diagnosis and Management |
9 |
| Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease |
8 |
| Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease |
8 |
| Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft |
8 |
| Procalcitonin and Liver Disease: A Literature Review |
8 |
| HCV Extrahepatic Manifestations |
8 |
| Hepatitis B Vaccine and Immunoglobulin: Key Concepts |
8 |
| Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review |
7 |
| Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma |
7 |
| A Systematic Literature Review of Syphilitic Hepatitis in Adults |
7 |
| HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation |
6 |
| Refining the Role of Simultaneous Liver Kidney Transplantation |
6 |
| Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review |
6 |
| Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma |
6 |
| Occult Hepatitis C Virus Infection: A Review |
5 |
| Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C |
5 |
| Mechanisms of Hepatic Cholestatic Drug Injury |
5 |
| Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances |
5 |
| Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization |
5 |
| Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study |
4 |
| Normothermic Ex-vivo Liver Perfusion and the Clinical Implications for Liver Transplantation |
4 |
| Non-invasive in vivo Imaging Grading of Liver Fibrosis |
4 |
| Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease |
4 |
| Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery |
4 |
| Role of Biologics in the Development of Autoimmune Hepatitis: A Review |
4 |
| Evidence for Viral Induction of Biliary Atresia: A Review |
4 |
| Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report |
4 |
| Diagnostic and Therapeutic Strategies for Peritoneal Tuberculosis: A Review |
4 |
| Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants |
3 |
| Biliary Mucinous Cystadenoma: A Review of the Literature |
3 |
| Characteristics and Outcomes of Acetaminophen Overdose and Hepatotoxicity in Thailand |
3 |
| Metabolic Acidosis in Critically Ill Cirrhotic Patients with Acute Kidney Injury |
3 |
| HBV cccDNA and Its Potential as a Therapeutic Target |
3 |
| Effect of Autologous Bone Marrow Stem Cell Therapy in Patients with Liver Cirrhosis: A Meta-analysis |
3 |
| Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era |
3 |
| Activation of Anti-tumor Immune Response by Ablation of HCC with Nanosecond Pulsed Electric Field |
3 |
| Autoimmune Hepatitis in the Asia-Pacific Area |
3 |
| CT-MRILI-RADSv2017: A Comprehensive Guidefor Beginners |
3 |
